Good news, for manufacturing remdesivir drug the Indian pharmaceutical company Hetero has received the approval of the Controller General of Indian Drugs (DCGI) for the production and marketing of the tested antiviral drug remdesivir under the brand name as covifor.
This medicine is proved as an effective drug for treating COVID-19 patients. In a statement released on Sunday, the company said that the generic version of Remedisvir will be sold in India under the brand name ‘covifor’.
The Hetero Group of Companies chairman B Partha Saradhi Reddy, said, “We will ensure that this product is available to patients across the country at the earliest.” He said that the company would ensure adequate stock to meet the current requirement. This drug will be available as a 100mg vial (injection).
Other than Hetero and Cipla, three other pharma compies BDR, Jubilant, Mylan, and DR Reddy’s Labs have also applied to CDSCO for permission to manufacture and market the drug in India, and they are awaiting permission.
The drug administered as an injection should be given at a dose of 200 mg a day and then 100 mg daily for five days. Cipla and Hetero Labs have already tied up with US pharma giant Gilead Sciences, the patent holder of drug remediesvir.
Remdesivir, developed by Gilead Sciences, has been approved for emergency use by the US Food and Drug Administration for the treatment of COVID-19. However, the drug testing additional clinical trials are still ongoing regarding the safety and effectiveness of the drug as a treatment for the virus. The Union Ministry of Health has used the anti-virus drug Remdesivir, an immunity in emergency, to treat covid-19.
The Ministry of Health stated that Remedisvir was included as Investigational therapy only for the purpose of emergency use, meaning that it is used for conditions.
On 29 May Gilead Sciences applied to the Indian Pharmaceutical Regulatory Agency, CDSCO for the import and marketing of Remedisvir. Permission was granted by DCGI under the Emergency Use Authority on 1 June after due deliberations.
for more information about the drug please visit official website.
Also read the another antiviral drug Favipirvir Fabiflu tablet